Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PrEmenopausal bReaSt cancEr adjuVant thERapy Benefit According to OncotypE DX Test

NCT06807749 is registered in ClinicalTrials.gov with Fondazione Policlinico Universitario Agostino Gemelli IRCCS as lead sponsor.

NCT NCT06807749
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06807749 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PrEmenopausal bReaSt cancEr adjuVant thERapy Benefit According to OncotypE DX Test
Lead sponsor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Phase
Observational
Overall status
Recruiting
Start date
December 24, 2025
Completion date
September 30, 2027
Enrollment
800 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer early stage breast cancer (stage 1-3)